Sinclair Pharma PLC (LON:SPH) Receives GBX 62 Average PT from Brokerages
Sinclair Pharma PLC (LON:SPH) has earned a consensus recommendation of “Buy” from the five brokerages that are currently covering the firm. Five investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have covered the stock in the last year is GBX 62 ($0.81).
SPH has been the topic of a number of recent analyst reports. Stifel Nicolaus increased their price target on shares of Sinclair Pharma PLC from GBX 49 ($0.64) to GBX 63 ($0.82) and gave the stock a “buy” rating in a research note on Wednesday, September 14th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Sinclair Pharma PLC in a research note on Thursday, September 15th. Jefferies Group cut their price target on shares of Sinclair Pharma PLC from GBX 60 ($0.78) to GBX 55 ($0.72) and set a “buy” rating on the stock in a research note on Wednesday, June 15th. N+1 Singer reaffirmed a “buy” rating on shares of Sinclair Pharma PLC in a research note on Wednesday, September 21st. Finally, Peel Hunt increased their price target on shares of Sinclair Pharma PLC from GBX 66 ($0.86) to GBX 68 ($0.89) and gave the stock a “buy” rating in a research note on Thursday, September 1st.
Sinclair Pharma PLC (LON:SPH) opened at 27.00 on Tuesday. The firm’s market cap is GBX 134.19 million. The company’s 50 day moving average is GBX 29.20 and its 200-day moving average is GBX 32.21. Sinclair Pharma PLC has a 52 week low of GBX 26.25 and a 52 week high of GBX 61.33.
About Sinclair Pharma PLC
Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.
Receive News & Stock Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related stocks with our FREE daily email newsletter.